ALSTODT LANCE 4
4 · BioRestorative Therapies, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
ALSTODT LANCE
DirectorPresident, CEO, COB
Transactions
- Award
Stock Option
2024-02-13+438,596→ 438,596 totalExercise: $1.45Exp: 2034-02-13→ Common Stock (438,596 underlying)
Holdings
- 189,505
Common Stock
- 293,479
Stock Option
Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying) - 42,059
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying) - 106,762
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (106,762 underlying)
Footnotes (5)
- [F1]Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
- [F2]The option is currently exercisable.
- [F3]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
- [F4]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
- [F5]The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.